Clinical Trial Update: Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating bendamustine plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Cristina Gasparetto | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN | Results posted: 2017-02-27